» Articles » PMID: 10064838

Ferritin, Transferrin and Iron Concentrations in the Cerebrospinal Fluid of Multiple Sclerosis Patients

Overview
Journal Brain Res
Specialty Neurology
Date 1999 Mar 5
PMID 10064838
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

The concentrations of ferritin, transferrin and iron were measured in the cerebrospinal fluid (CSF) of multiple sclerosis (MS) and control patients. Ferritin levels were significantly elevated in the CSF of chronic progressive active MS patients (4.71+/-0.54 ng/ml) compared to levels in normal individuals (3.07+/-0.17 ng/ml). MS patients with active or stable relapsing-remitting disease had ferritin levels that were comparable to those found in normal individuals. There were no significant differences in transferrin or iron levels in the CSF between MS and normal individuals. Both ferritin and transferrin levels were elevated in patients that had high CSF IgG values but not in patients with a high IgG index. Since ferritin binds iron, the increase of CSF ferritin levels in chronic progressive MS patients could be a defense mechanism to protect against iron induced oxidative injury. Ferritin levels could be a laboratory measure that helps to distinguish between chronic progressive and relapsing-remitting MS.

Citing Articles

Circulatory Indicators of Lipid Peroxidation, the Driver of Ferroptosis, Reflect Differences between Relapsing-Remitting and Progressive Multiple Sclerosis.

Stojkovic L, Djordjevic A, Stefanovic M, Stankovic A, Dincic E, Djuric T Int J Mol Sci. 2024; 25(20).

PMID: 39456806 PMC: 11507982. DOI: 10.3390/ijms252011024.


Alteration of Iron Concentration in Alzheimer's Disease as a Possible Diagnostic Biomarker Unveiling Ferroptosis.

Ficiara E, Munir Z, Boschi S, Caligiuri M, Guiot C Int J Mol Sci. 2021; 22(9).

PMID: 33923052 PMC: 8123284. DOI: 10.3390/ijms22094479.


Metal Imbalance in Neurodegenerative Diseases with a Specific Concern to the Brain of Multiple Sclerosis Patients.

Dales J, Desplat-Jego S Int J Mol Sci. 2020; 21(23).

PMID: 33266021 PMC: 7730295. DOI: 10.3390/ijms21239105.


The Role of Iron Metabolism in Fatigue, Depression, and Quality of Life in Multiple Sclerosis Patients.

Knyszynska A, Radecka A, Zabielska P, Luczak J, Karakiewicz B, Lubkowska A Int J Environ Res Public Health. 2020; 17(18).

PMID: 32962047 PMC: 7558798. DOI: 10.3390/ijerph17186818.


Serum hepcidin levels in multiple sclerosis.

Bsteh G, Haschka D, Tymoszuk P, Berek K, Petzer V, Hegen H Mult Scler J Exp Transl Clin. 2019; 5(4):2055217319885984.

PMID: 31723437 PMC: 6831977. DOI: 10.1177/2055217319885984.